QFT Transplant, female surgeon at the operating table
icon-infectious-disease-testing
Infectious disease

Protect transplant patients with QuantiFERON

Infection prevention is critical for transplant patients

Each year, ~150,000 transplants are performed worldwide, requiring immunosuppressive therapies to prevent acute rejection.

Immunocompromised transplant patients are highly susceptible to post-op infections – including CMV infection and CMV disease.

These conventional and opportunistic infections are an important cause of morbidity and mortality in transplant recipients.

QFT Transplant, Doctors discussing a patient's medical Chart

Are you managing infection risk?

Doctors office, QuantiFERONPrevention (QFT), nurse

What can you do when viral load assays and CMV IgG antibody testing don’t give you a complete picture of your transplant patient’s immune response to infection?

Rather than detecting pathogens directly, QuantiFERON assays will monitor your patient’s cell-mediated immune response.

This complementary approach helps you assess the risk of infection and guides your patient management.

Protect your transplant patients with QuantiFERON immune monitoring

Simple, consistent testing

All QuantiFERON in vitro diagnostic tests use the same core ELISA testing process for easy integration. Whole blood samples are collected into custom blood collection tubes, which are used to measure interferon gamma production in response to specific or generic immune stimulants.
QuantiFERON Transplantation Workflow

Discover more diagnostic products